Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by INVSTIGAT0Ron Jul 10, 2019 9:29am
145 Views
Post# 29903239

RE:RE:RE:Earnings

RE:RE:RE:EarningsAll I'm looking for is guidance as the numbers are pretty predictable. 115-120 million revenue. With no writedowns and DD/ECE news I am back all in (mainly for the fall run/edible hype). I'd also like to see some more info on global operations because my impression is that LATAM is currently bringing in next to nothing and Germany only has the potential for a few extra million by 2021. Where exactly are all the plants currently being grown in Jamaica going? Unless there is global growth, Canada alone is only enough to support the current cap of 2.2 billion realisitically for at least 2-3 more years. Also looking to see a big product launch for the extracts market in 2020. I want to see sports drinks, edibles, recreational beverages and topicals, where and how we're going to produce them and a timeline for these products. I want a BIT more than simply finding out on reddit that Aphria filed for a bunch of trademark names with "CANNA" thrown in front. Even though I'm sounding super bearish right now I still believe that Aphria has by far the most potential if they can execute and create products and brands that people love. 
Bullboard Posts